Laboratory testing in management of patients with suspected Ebolavirus disease: infection control and safety

Summary: If routine laboratory safety precautions are followed, the risk of laboratory-acquired infection from handling specimens from patients with Ebolavirus disease (EVD) is very low, especially in the early ‘dry’ stage of disease. In Australia, border screening to identify travellers returning from EVD-affected west African countries during the 2014–2015 outbreak has made it unlikely that specimens from patients with unrecognised EVD would be sent to a routine diagnostic laboratory. Australian public health and diagnostic laboratories associated with hospitals designated for the care of patients with EVD have developed stringent safety precautions for EVD diagnostic and other tests likely to be required for supportive care of the sickest (and most infectious) patients with EVD, including as wide a range of point-of-care tests as possible. However, it is important that the stringent requirements for packaging, transport and testing of specimens that might contain Ebolavirus—which is a tier 1 security sensitive biology agent—do not delay the diagnosis and appropriate management of other potentially serious but treatable infectious diseases, which are far more likely causes of a febrile illness in people returning from west Africa. If necessary, urgent haematology, biochemistry and microbiological tests can be performed safely, whilst awaiting the results of EVD tests, in a PC-2 laboratory with appropriate precautions including: use of recommended personal protecti...
Source: Pathology - Category: Pathology Tags: Special Theme Section: Laboratory Preparedness for Ebolavirus Disease: Guest Editor: Sharon C-A. Chen Source Type: research